GlassScriptPhysician profile
Jimmie L Dotson
NPI 1932300571
$8,019.04
in general payments reported to CMS, 2019-2025
38 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,363 · 2020: $528 · 2021: $1,394 · 2022: $2,235 · 2023: $1,331 · 2024: $726 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,499.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,962.88 | 2019-2025 | |
| Angiodynamics, INC. | $1,144.78 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $878.45 | 2020-2024 | Jot Dx |
| Amgen INC. | $398.75 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $397.48 | 2019-2024 | Xarelto |
| Pfizer INC. | $395.00 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $256.29 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $239.24 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.94 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $204.95 | 2019-2024 | |
| Novo Nordisk INC | $186.94 | 2025 | Wegovy |
| Abiomed | $171.85 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $162.52 | 2020-2024 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.63 | 2019-2025 | Jardiance |
| Livanova USA, INC. | $130.35 | 2023 | Tandemlife |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmie Dotson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.